Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mayumi Nakagawa

Concepts (204)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
14
2019
157
5.420
 Why?
Human papillomavirus 16
11
2021
51
4.390
 Why?
Papillomavirus Vaccines
7
2021
66
4.010
 Why?
Uterine Cervical Neoplasms
8
2021
285
3.090
 Why?
Oncogene Proteins, Viral
11
2011
59
2.980
 Why?
Papillomaviridae
7
2019
106
2.830
 Why?
Repressor Proteins
9
2011
170
2.480
 Why?
Epitopes, T-Lymphocyte
7
2018
32
2.330
 Why?
Cancer Vaccines
3
2021
102
1.910
 Why?
T-Lymphocytes
6
2021
334
1.690
 Why?
Candida
4
2018
61
1.640
 Why?
CD8-Positive T-Lymphocytes
6
2018
111
1.620
 Why?
Cervix Uteri
3
2021
54
1.060
 Why?
Cervical Intraepithelial Neoplasia
2
2015
42
1.030
 Why?
Immunity, Cellular
4
2013
85
0.890
 Why?
Lymphocytes, Tumor-Infiltrating
1
2021
80
0.870
 Why?
Langerhans Cells
3
2018
11
0.860
 Why?
Epitopes
2
2015
84
0.860
 Why?
Neoplasms
2
2021
1158
0.830
 Why?
Viral Load
2
2019
87
0.800
 Why?
Cell Cycle Checkpoints
1
2019
34
0.780
 Why?
HLA Antigens
4
2006
52
0.760
 Why?
Health Education
1
2021
190
0.750
 Why?
CD4-Positive T-Lymphocytes
3
2018
190
0.680
 Why?
Adult
19
2021
14064
0.640
 Why?
Plasma Exchange
2
2014
33
0.620
 Why?
Health Knowledge, Attitudes, Practice
1
2021
546
0.610
 Why?
Humans
37
2021
51226
0.600
 Why?
Cross Protection
1
2015
6
0.600
 Why?
T-Lymphocytes, Regulatory
2
2016
86
0.600
 Why?
Colposcopy
1
2015
19
0.580
 Why?
Interleukin-12
2
2018
35
0.580
 Why?
Adjuvants, Immunologic
2
2018
64
0.570
 Why?
Immunity, Innate
1
2015
108
0.550
 Why?
Female
25
2021
28342
0.550
 Why?
Lectins, C-Type
1
2013
30
0.540
 Why?
Interferon-gamma
2
2012
196
0.540
 Why?
Health
1
2013
29
0.540
 Why?
Papillomavirus E7 Proteins
8
2018
35
0.540
 Why?
Patient Selection
1
2015
293
0.500
 Why?
Afibrinogenemia
1
2012
5
0.500
 Why?
Enzyme-Linked Immunospot Assay
1
2012
2
0.490
 Why?
T-Lymphocytes, Cytotoxic
4
2009
76
0.480
 Why?
Young Adult
8
2021
4171
0.480
 Why?
Middle Aged
13
2021
13329
0.460
 Why?
Plateletpheresis
1
2010
8
0.440
 Why?
Warts
1
2010
23
0.440
 Why?
Antigens, Fungal
1
2010
30
0.440
 Why?
Blood Preservation
1
2010
31
0.430
 Why?
Dermatitis
1
2010
37
0.430
 Why?
Cell Proliferation
5
2021
1120
0.420
 Why?
Blood Proteins
1
2010
102
0.420
 Why?
Anaphylaxis
1
2010
70
0.410
 Why?
Telemedicine
1
2015
398
0.390
 Why?
Antigens, Viral
2
2009
54
0.380
 Why?
Human papillomavirus 18
1
2008
10
0.370
 Why?
Cells, Cultured
5
2021
1828
0.370
 Why?
Immunotherapy
1
2010
243
0.370
 Why?
Blood Platelets
1
2010
302
0.350
 Why?
Vaccinia virus
1
2007
7
0.340
 Why?
Host-Pathogen Interactions
2
2021
151
0.340
 Why?
Dendritic Cells
1
2008
148
0.340
 Why?
Immunophenotyping
1
2007
128
0.330
 Why?
Immunoenzyme Techniques
1
2007
173
0.330
 Why?
Isoantibodies
1
2004
34
0.290
 Why?
Neoplasm Grading
2
2021
132
0.280
 Why?
Lead
1
2004
34
0.280
 Why?
Cell Line, Tumor
5
2021
1476
0.280
 Why?
Infant, Very Low Birth Weight
1
2004
53
0.280
 Why?
Neutropenia
1
2004
116
0.280
 Why?
DNA, Viral
3
2011
151
0.260
 Why?
Blood Transfusion
1
2004
126
0.260
 Why?
High-Throughput Nucleotide Sequencing
2
2021
194
0.250
 Why?
Aged
8
2021
10169
0.250
 Why?
Capsid Proteins
1
2002
24
0.250
 Why?
Early Detection of Cancer
2
2021
130
0.240
 Why?
Antibody Formation
1
2002
65
0.240
 Why?
Adolescent
5
2021
6735
0.240
 Why?
Genes, T-Cell Receptor
1
2021
4
0.240
 Why?
Clone Cells
3
2007
87
0.240
 Why?
Clinical Trials, Phase I as Topic
1
2021
30
0.230
 Why?
Remission Induction
1
2021
218
0.220
 Why?
Left-Right Determination Factors
1
2020
1
0.220
 Why?
Cystadenocarcinoma, Serous
1
2021
70
0.220
 Why?
Nodal Protein
1
2020
3
0.220
 Why?
Vaginal Smears
2
2011
31
0.220
 Why?
Videotape Recording
1
2021
35
0.220
 Why?
Cytokines
2
2016
683
0.220
 Why?
Pilot Projects
2
2021
775
0.220
 Why?
Treatment Outcome
3
2021
5480
0.220
 Why?
Lymphocyte Activation
1
2021
213
0.220
 Why?
Amino Acid Sequence
3
2008
761
0.210
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
309
0.200
 Why?
Metagenome
1
2019
49
0.200
 Why?
Feasibility Studies
1
2021
399
0.200
 Why?
Glioblastoma
1
2020
81
0.200
 Why?
Health Behavior
1
2021
270
0.180
 Why?
Up-Regulation
1
2020
528
0.180
 Why?
Dose-Response Relationship, Drug
2
2016
1556
0.180
 Why?
Multiple Myeloma
1
2012
2714
0.180
 Why?
HLA-B Antigens
2
2008
7
0.180
 Why?
Leukocytes, Mononuclear
2
2016
136
0.170
 Why?
DNA
1
2021
565
0.170
 Why?
Brain Neoplasms
1
2020
249
0.170
 Why?
Bacteria
1
2019
229
0.170
 Why?
Ovarian Neoplasms
1
2021
441
0.160
 Why?
Age Factors
1
2021
1246
0.160
 Why?
Histocompatibility Antigens Class II
2
2008
42
0.160
 Why?
Cell Line
2
2012
1215
0.160
 Why?
Vaccines, Subunit
1
2016
21
0.160
 Why?
Male
8
2021
27647
0.160
 Why?
Head and Neck Neoplasms
1
2019
310
0.150
 Why?
Adaptive Immunity
1
2015
38
0.150
 Why?
Leukocyte Count
2
2004
82
0.140
 Why?
Chromatography, Liquid
1
2016
240
0.140
 Why?
Molecular Sequence Data
2
2008
971
0.140
 Why?
Tandem Mass Spectrometry
1
2016
241
0.140
 Why?
Factor VIII
1
2014
23
0.140
 Why?
Vaccination
1
2016
189
0.140
 Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
18
0.140
 Why?
ADAM Proteins
1
2014
26
0.140
 Why?
Antigens, CD1
1
2013
8
0.140
 Why?
Peptides
2
2006
280
0.140
 Why?
Mannose-Binding Lectins
1
2013
10
0.140
 Why?
Receptors, Pattern Recognition
1
2013
5
0.140
 Why?
Proteome
1
2016
168
0.140
 Why?
Indicators and Reagents
1
2013
58
0.140
 Why?
Intracellular Space
1
2013
30
0.140
 Why?
Skin Tests
1
2013
57
0.140
 Why?
Time Factors
1
2021
3392
0.130
 Why?
Cadherins
1
2013
78
0.130
 Why?
Proteomics
1
2016
314
0.130
 Why?
Communication
1
2015
260
0.120
 Why?
Research Design
1
2015
348
0.120
 Why?
Rural Health Services
1
2015
200
0.120
 Why?
Socioeconomic Factors
1
2015
629
0.120
 Why?
Antigens, CD
1
2013
264
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
699
0.120
 Why?
Longitudinal Studies
2
2005
684
0.110
 Why?
Injections, Intralesional
1
2010
40
0.110
 Why?
Isotonic Solutions
1
2010
23
0.110
 Why?
Platelet Transfusion
1
2010
34
0.110
 Why?
P-Selectin
1
2010
45
0.110
 Why?
Sodium Chloride
1
2010
62
0.110
 Why?
Platelet Aggregation
1
2010
90
0.110
 Why?
Platelet Activation
1
2010
65
0.100
 Why?
Hypersensitivity
1
2010
65
0.100
 Why?
HLA-A Antigens
1
2008
14
0.090
 Why?
Antigen Presentation
1
2008
25
0.090
 Why?
Immunologic Memory
1
2008
31
0.090
 Why?
Histocompatibility Antigens Class I
1
2008
44
0.090
 Why?
Polymerase Chain Reaction
1
2010
532
0.090
 Why?
DNA, Recombinant
1
2007
18
0.090
 Why?
African Americans
1
2013
711
0.090
 Why?
Genes, MHC Class I
1
2006
11
0.080
 Why?
Signal Transduction
2
2020
1812
0.080
 Why?
Binding, Competitive
1
2006
133
0.080
 Why?
Arkansas
1
2013
2146
0.080
 Why?
Retrospective Studies
2
2010
5788
0.080
 Why?
Animals
2
2019
14412
0.080
 Why?
Calgranulin B
1
2005
7
0.070
 Why?
Calgranulin A
1
2005
9
0.070
 Why?
Neoplasm Staging
1
2008
799
0.070
 Why?
Immunomagnetic Separation
1
2004
10
0.070
 Why?
Epitope Mapping
1
2004
13
0.070
 Why?
Risk Factors
1
2013
3924
0.070
 Why?
Phosphorylation
2
2020
624
0.060
 Why?
Sensitivity and Specificity
1
2005
960
0.060
 Why?
Tumor Virus Infections
1
2002
44
0.060
 Why?
Antibodies, Viral
1
2002
87
0.060
 Why?
Lactobacillus
1
2021
8
0.060
 Why?
SOX Transcription Factors
1
2021
4
0.060
 Why?
Immunoglobulin G
1
2002
214
0.060
 Why?
Cytodiagnosis
1
2021
43
0.060
 Why?
Neuroendocrine Cells
1
2021
11
0.060
 Why?
Biological Specimen Banks
1
2021
25
0.060
 Why?
Cobalt
1
2020
15
0.060
 Why?
Cytoplasm
1
2021
111
0.060
 Why?
Vulnerable Populations
1
2020
40
0.050
 Why?
Cell Hypoxia
1
2020
92
0.050
 Why?
Epithelial-Mesenchymal Transition
1
2020
54
0.050
 Why?
Neoplastic Stem Cells
1
2021
102
0.050
 Why?
Recurrence
1
2002
690
0.050
 Why?
Community Health Workers
1
2020
52
0.050
 Why?
Cohort Studies
1
2004
1485
0.050
 Why?
Cell Movement
1
2021
303
0.050
 Why?
Multivariate Analysis
1
2021
688
0.050
 Why?
Sequence Analysis, DNA
1
2019
259
0.050
 Why?
Cell Survival
1
2020
687
0.050
 Why?
Immunity, Humoral
1
2018
22
0.050
 Why?
Cell Differentiation
1
2021
749
0.040
 Why?
Phenotype
1
2021
814
0.040
 Why?
Models, Biological
1
2021
846
0.040
 Why?
Infant, Newborn
1
2004
2740
0.040
 Why?
Mass Screening
1
2020
370
0.040
 Why?
Gene Expression Regulation, Neoplastic
1
2020
880
0.040
 Why?
Prognosis
1
2021
2077
0.040
 Why?
Autoantibodies
1
2014
122
0.030
 Why?
Immunosuppressive Agents
1
2014
252
0.030
 Why?
Combined Modality Therapy
1
2014
703
0.030
 Why?
Mice, Inbred C57BL
1
2018
2029
0.030
 Why?
Mice
1
2018
6254
0.020
 Why?
Casein Kinase II
1
2005
11
0.020
 Why?
Cell Division
1
2005
367
0.020
 Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (204) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department